Hi, welcome back!If you like the post Share it!
BullsInvest.com is not checking the facts behind the Guest Posts of its users.
Our Latest News
SHANGHAI (Reuters) - China's central bank vowed on Friday to crack down on illegal activities of cryptocurrency trading, banning overseas exchanges from providing services to mainland investors via Internet.
Cryptocurrencies were back up on Thursday, after being hammered in the past week, as acceptance by mainstream companies continues.
European stocks recovered some of yesterday's losses on Tuesday morning in London, as new data from the Office for National Statistics showed the UK's public sector borrowing had seen its second highest August on record.
Cross-chain DeFi platform pNetwork has been hacked on Binance Smart Chain to the tune of approximately $12.7 million worth of Bitcoin.
Learn why Cocrystal Pharma Stock Gains over 150%
Cocrystal Pharma (COCP) - Get Report shares more than doubled in Tuesday trading after the drugmaker reported progress on its COVID-19 antiviral drug candidates.
The stock recently traded at $3.24 compared with Monday's close at $1.24. The shares have more than tripled in the past six months as investors look for opportunities in makers of COVID treatments.
“We are aggressively developing novel coronavirus protease inhibitors for COVID-19 prophylactic and therapeutic use,” said Sam Lee, president of Cocrystal, Bothell, Wash.
“These drug candidates bind to a highly conserved region of the active site of SARS-CoV-2 protease that is required for SARS-CoV-2 viral replication.
“Our high-resolution x-ray cocrystal structures further confirmed the specific covalent interaction with this conserved region of the proteases of the coronaviruses SARS-CoV-2, SARS-CoV and MERS-CoV viruses.”
Further, “We believe that, due to their novel mechanism of action, our protease inhibitors are likely to be effective against new variants of SARS-CoV-2,” he said.
“This may include the recent variants first identified in the United Kingdom, South Africa, Brazil and India, which may be more contagious forms of the virus and may evade immunity produced by vaccines or previous infection.”
In other Covid-related news, Pfizer PFE on Tuesday posted stronger-than-expected first-quarter earnings and lifted its full-year profit guidance.
The New York health-care group expects to generate around $26 billion in worldwide sales for its coronavirus vaccine.
On Monday, the European Union's drug regulator said it was evaluating the vaccine produced by Pfizer and BioNTech (BNTX) - Get Report for use in children between ages 12 to 15.
On Monday, specialty-diagnostics company Precipio said it launched its COVID-19 rapid antibody test on Amazon's (AMZN) - Get Report platform.